Hepatitis C virus entry: Potential receptors and their biological functions

Journal of General Virology

Volumn 87, Issue 5, 2006, Pages 1075-1084

  Cocquerel, Laurence ^a   Voisset, Cécile ^a   Dubuisson, Jean ^a  

^a INSTITUT DE BIOLOGIE DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASIALOGLYCOPROTEIN RECEPTOR; CD209 ANTIGEN; CD81 ANTIGEN; GLYCOPROTEIN E2; LOW DENSITY LIPOPROTEIN RECEPTOR; MANNOSE BINDING LECTIN; PROTEOHEPARAN SULFATE; SCAVENGER RECEPTOR BI; TETRASPANIN; VIRUS GLYCOPROTEIN; VIRUS RECEPTOR;

ANIMAL CELL; CELL CULTURE; CELL LINE; CONTROLLED STUDY; GENE AMPLIFICATION; HEPATITIS C; HEPATITIS C VIRUS; LIFE CYCLE; LIVER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MODIFICATION; REVIEW; VIRUS CORE; VIRUS PARTICLE; VIRUS TRANSMISSION;

ANTIGENS, CD; ANTIGENS, CD36; GLYCOSAMINOGLYCANS; HEPACIVIRUS; HEPATOCYTES; HUMANS; LECTINS, C-TYPE; RECEPTORS, LDL; RECEPTORS, VIRUS; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 33646134842     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81646-0     Document Type: Review

References (95)

1. Acton, S. L., Scherer, P. E., Lodish, H. F. & Krieger, M. (1994). Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem 269, 21003-21009.
2. Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H. & Krieger, M. (1996). Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271, 518-520.
3. Agnello, V., Ábel, G., Elfahal, M., Knight, G. B. & Zhang, Q.-X. (1999). Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci U S A 96, 12766-12771.
4. André, P., Komurian-Pradel, F., Deforges, S. & 7 other authors (2002). Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 76, 6919-6928.
5. Babitt, J., Trigatti, B., Rigotti, A., Smart, E. J., Anderson, R. G. W., Xu, S. & Krieger, M. (1997). Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J Biol Chem 272, 13242-13249.
6. Barth, H., Schäfer, C., Adah, M. I. & 10 other authors (2003). Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J Biol Chem 278, 41003-41012.
7. Barth, H., Cerino, R., Arcuri, M. & 12 other authors (2005). Scavenger receptor class B type I and hepatitis C virus infection of primary Tupaia hepatocytes. J Virol 79, 5774-5785.
8. Bartosch, B., Dubuisson, J. & Cosset, F.-L. (2003a). Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 197, 633-642.
9. Bartosch, B., Vitelli, A., Granier, C. & 7 other authors (2003b). Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J Biol Chem 278, 41624-41630.
10. Bartosch, B., Verney, G., Dreux, M., Donot, P., Morice, Y., Penin, F., Pawlotsky, J.-M., Lavillette, D. & Cosset, F.-L. (2005). An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. J Virol 79, 8217-8229.
11. Bashirova, A. A., Geijtenbeek, T. B. H., van Duijnhoven, G. C. F. & 10 other authors (2001). A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J Exp Med 193, 671-678.
12. Baumert, T. F., Ito, S., Wong, D. T. & Liang, T. J. (1998). Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. J Virol 72, 3827-3836.
13. Boucheix, C. & Rubinstein, E. (2001). Tetraspanins. Cell Mol Life Sci 58, 1189-1205.
14. Brazzoli, M., Helenius, A., Foung, S. K. H., Houghton, M., Abrignani, S. & Merola, M. (2005). Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells. Virology 332, 438-453.
15. Callens, N., Ciczora, Y., Bartosch, B., Vu-Dac, N., Cosset, F.-L., Pawlotsky, J.-M., Penin, F. & Dubuisson, J. (2005). Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein E2 contribute to virus entry. J Virol 79, 15331-15341.
16. Calvo, D. & Vega, M. A. (1993). Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family. J Biol Chem 268, 18929-18935.
17. Cao, G., Garcia, C. K., Wyne, K. L., Schultz, R. A., Parker, K. L. & Hobbs, H. H. (1997). Structure and localization of the human gene encoding SR-BI/CLA-1: evidence for transcriptional control by steroidogenic factor 1. J Biol Chem 272, 33068-33076.
18. Cocquerel, L., Kuo, C.-C., Dubuisson, J. & Levy, S. (2003). CD81-dependent binding of hepatitis C virus E1E2 heterodimers. J Virol 77, 10677-10683.
19. Cormier, E. G., Tsamis, F., Kajumo, F., Durso, R. J., Gardner, J. P. & Dragic, T. (2004a). CD81 is an entry coreceptor for hepatitis C virus. Proc Natl Acad Sci U S A 101, 7270-7274.
20. Cormier, E. G., Durso, R. J., Tsamis, F., Boussemart, L., Manix, C., Olson, W. C., Gardner, J. P. & Dragic, T. (2004b). L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. Proc Natl Acad Sci U S A 101, 14067-14072.
21. Drummer, H. E., Wilson, K. A. & Poumbourios, P. (2002). Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81. J Virol 76, 11143-11147.
22. Drummer, H. E., Maerz, A. & Poumbourios, P. (2003). Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins. FEBS Lett 546, 385-390.
23. Drummer, H. E., Wilson, K. A. & Poumbourios, P. (2005). Determinants of CD81 dimerization and interaction with hepatitis C virus glycoprotein E2. Biochem Biophys Res Commun 328, 251-257.
24. Engering, A., Geijtenbeek, T. B. H., van Vliet, S. J. & 8 other authors (2002). The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J Immunol 168, 2118-2126.
25. Flint, M., Maidens, C., Loomis-Price, L. D., Shotton, C., Dubuisson, J., Monk, P., Higginbottom, A., Levy, S. & McKeating, J. A. (1999)., Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J Virol 73, 6235-6244.
26. Forns, X., Allander, T., Rohwer-Nutter, P. & Bukh, J. (2000). Characterization of modified hepatitis C virus E2 proteins expressed on the cell surface. Virology 274, 75-85.
27. Gardner, J. P., Durso, R. J., Arrigale, R. R., Donovan, G. P., Maddon, P. J., Dragic, T. & Olson, W. C. (2003). L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proc Natl Acad Sci U S A 100, 4498-4503.
28. Gu, X., Trigatti, B., Xu, S., Acton, S., Babitt, J. & Krieger, M. (1998). The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. J Biol Chem 273, 26338-26348.
29. Higginbottom, A., Quinn, E. R., Kuo, C.-C. & 7 other authors (2000). Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J Virol 74, 3642-3649.
30. Higginbottom, A., Takahashi, Y., Bolling, L., Coonrod, S. A., White, J. M., Partridge, L. J. & Monk, P. N. (2003). Structural requirements for the inhibitory action of the CD9 large extracellular domain in sperm/ oocyte binding and fusion. Biochem Biophys Res Commun 311, 208-214.
31. Hsu, M., Zhang, J., Flint, M., Logvinoff, C., Cheng-Mayer, C., Rice, C. M. & McKeating, J. A. (2003). Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci U S A 100, 7271-7276.
32. Huang, Z. H., Gu, D., Lange, Y. & Mazzone, T. (2003). Expression of scavenger receptor BI facilitates sterol movement between the plasma membrane and the endoplasmic reticulum in macrophages. Biochemistry 42, 3949-3955.
33. Imai, T. & Yoshie, O. (1993). C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type 1 are both members of the transmembrane 4 superfamily and associate with each other and with CD4 or CD8 in T cells. J Immunol 151, 6470-6481.
34. Kaji, K., Oda, S., Miyazaki, S. & Kudo, A. (2002). Infertility of CD9-deficient mouse eggs is reversed by mouse CD9, human CD9, or mouse CD81; polyadenylated mRNA injection developed for molecular analysis of sperm-egg fusion. Dev Biol 247, 327-334.
35. Kazarov, A. R., Yang, X., Stipp, C. S., Sehgal, B. & Hemler, M. E. (2002). An extracellular site on tetraspanin CD151 determines α3 and α6 integrin-dependent cellular morphology. J Cell Biol 158, 1299-1309.
36. Kellner-Weibel, G., de La Llera-Moya, M., Connelly, M. A., Stoudt, G., Christian, A. E., Haynes, M. P., Williams, D. L. & Rothblat, G. H. (2000). Expression of scavenger receptor BI in COS-7 cells alters cholesterol content and distribution. Biochemistry 39, 221-229.
37. Kitadokoro, K., Bordo, D., Galli, G., Petracca, R., Falugi, F., Abrignani, S., Grandi, G. & Bolognesi, M. (2001). CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs. EMBO J 20, 12-18.
38. Koppel, E. A., van Gisbergen, K. P. J. M., Geijtenbeek, T. B. H. & van Kooyk, Y. (2005). Distinct functions of DC-SIGN and its homologues L-SIGN (DC-SIGNR) and mSIGNR1 in pathogen recognition and immune regulation. Cell Microbiol 7, 157-165.
39. Krieger, M. & Kozarsky, K. (1999). Influence of the HDL receptor SR-BI on atherosclerosis. Curr Opin Lipidol 10, 491-497.
40. Kuhmann, S. E., Platt, E. J., Kozak, S. L. & Kabat, D. (2000). Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1. J Virol 74, 7005-7015.
41. Landschulz, K. T., Pathak, R. K., Rigotti, A., Krieger, M. & Hobbs, H. H. (1996). Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J Clin Invest 98, 984-995.
42. Lavillette, D., Tarr, A. W., Voisset, C. & 7 other authors (2005). Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Hepatology 41, 265-274.
43. Levy, S. & Shoham, T. (2005). Protein-protein interactions in the tetraspanin web. Physiology (Bethesda) 20, 218-224.
44. Lindenbach, B. D. & Rice, C. M. (2001). Flaviviridae: the viruses and their replication. In Fields Virology, 4th edn, pp. 991-1041. Edited by D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman & S. E. Straus. Philadelphia, PA: Lippincott Williams & Wilkins.
45. Lindenbach, B. D., Evans, M. J., Syder, A. J. & 8 other authors (2005). Complete replication of hepatitis C virus in cell culture. Science 309, 623-626.
46. Lozach, P.-Y., Lortat-Jacob, H., de Lacroix de Lavalette, A. & 9 other authors (2003). DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J Biol Chem 278, 20358-20366.
47. Lozach, P.-Y., Amara, A., Bartosch, B., Virelizier, J.-L., Arenzana-Seisdedos, F., Cosset, F.-L. & Altmeyer, R. (2004). C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles. J Biol Chem 279, 32035-32045.
48. McKeating, J. A., Zhang, L. Q., Logvinoff, C. & 8 other authors (2004). Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner. J Virol 78, 8496-8505.
49. Meunier, J.-C., Engle, R. E., Faulk, K. & 7 other authors (2005). Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc Natl Acad Sci U S A 102, 4560-4565.
50. Monazahian, M., Böhme, I., Bonk, S., Koch, A., Scholz, C., Grethe, S. & Thomssen, R. (1999). Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J Med Virol 57, 223-229.
51. Op De Beeck, A. & Dubuisson, J. (2003). Another putative receptor for hepatitis C virus. Hepatology 37, 705-707.
52. Op De Beeck, A., Cocquerel, L. & Dubuisson, J. (2001). Biogenesis of hepatitis C virus envelope glycoproteins. J Gen Virol 82, 2589-2595.
53. Op De Beeck, A., Voisset, C., Bartosch, B., Ciczora, Y., Cocquerel, L., Keck, Z., Foung, S., Cosset, F.-L. & Dubuisson, J. (2004). Characterization of functional hepatitis C virus envelope glycoproteins. J Virol 78, 2994-3002.
54. Owsianka, A., Clayton, R. F., Loomis-Price, L. D., McKeating, J. A. & Patel, A. H. (2001). Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2. J Gen Virol 82, 1877-1883.
55. Patel, A. H., Wood, J., Penin, F., Dubuisson, J. & McKeating, J. A. (2000). Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding. J Gen Virol 81, 2873-2883.
56. Patel, A. H., Owsianka, A., Timms, J., Tarr, A. W. & Ball, J. K. (2005). Determining the effect of mutations within CD81 binding domains: identification of E2 residues critical for CD81 interaction. In Abstracts of the 12th International Symposium on Hepatitis C Virus and Related Viruses. 2-6 October 2005, Montréal, Canada.
57. Peng, Y., Akmentin, W., Connelly, M. A., Lund-Katz, S., Phillips, M. C. & Williams, D. L. (2004). Scavenger receptor BI (SR-BI) clustered on microvillar extensions suggests that this plasma membrane domain is a way station for cholesterol trafficking between cells and high-density lipoprotein. Mol Biol Cell 15, 384-396.
58. Petracca, R., Falugi, F., Galli, G. & 9 other authors (2000). Structure-function analysis of hepatitis C virus envelope-CD81 binding. J Virol 74, 4824-4830.
59. Philips, J. A., Rubin, E. J. & Perrimon, N. (2005). Drosophila RNAi screen reveals CD36 family member required for mycobacterial infection. Science 309, 1251-1253.
60. Pileri, P., Uematsu, Y., Campagnoli, S. & 8 other authors (1998). Binding of hepatitis C virus to CD81. Science 282, 938-941.
61. Pöhlmann, S., Zhang, J., Baribaud, F. & 7 other authors (2003). Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol 77, 4070-4080.
62. Reaven, E., Nomoto, A., Leers-Sucheta, S., Temel, R., Williams, D. L. & Azhar, S. (1998). Expression and microvillar localization of scavenger receptor, class B, type I (a high density lipoprotein receptor) in luteinized and hormone-desensitized rat ovarian models. Endocrinology 139, 2847-2856.
63. Reaven, E., Zhan, L., Nomoto, A., Leers-Sucheta, S. & Azhar, S. (2000). Expression and microvillar localization of scavenger receptor class B, type I (SR-BI) and selective cholesteryl ester uptake in Leydig cells from rat testis. J Lipid Res 41, 343-356.
64. Reaven, E., Leers-Sucheta, S., Nomoto, A. & Azhar, S. (2001). Expression of scavenger receptor class B type 1 (SR-BI) promotes microvillar channel formation and selective cholesteryl ester transport in a heterologous reconstituted system. Proc Natl Acad Sci U S A 98, 1613-1618.
65. Rhainds, D. & Brissette, L. (2004). The role of scavenger receptor class B type I (SR-BI) in lipid trafficking: defining the rules for lipid traders. Int J Biochem Cell Biol 36, 39-77.
66. Rigotti, A., Edelman, E. R., Seifert, P., Iqbal, S. N., DeMattos, R. B., Temel, R. E., Krieger, M. & Williams, D. L. (1996). Regulation by adrenocorticotropic hormone of the in vivo expression of scavenger receptor class B type I (SR-BI), a high density lipoprotein receptor, in steroidogenic cells of the murine adrenal gland. J Biol Chem 271, 33545-33549.
67. Rigotti, A., Trigatti, B., Babitt, J., Penman, M., Xu, S. & Krieger, M. (1997). Scavenger receptor BI - a cell surface receptor for high density lipoprotein. Curr Opin Lipidol 8, 181-188.
68. Roccasecca, R., Ansuini, H., Vitelli, A. & 11 other authors (2003). Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2. J Virol 77, 1856-1867.
69. Rosa, D., Campagnoli, S., Moretto, C. & 11 other authors (1996). A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci U S A 93, 1759-1763.
70. Rubinstein, E., Ziyyat, A., Prenant, M., Wrobel, E., Wolf, J.-P., Levy, S., Le Naour, F. & Boucheix, C. (2006). Reduced fertility of female mice lacking CD81. Dev Biol 290, 351-358.
71. Saunier, B., Triyatni, M., Ulianich, L., Maruvada, P., Yen, P. & Kohn, L. D. (2003). Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes. J Virol 77, 546-559.
72. Scarselli, E., Ansuini, H., Cerino, R. & 7 other authors (2002). The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21, 5017-5025.
73. Seigneuret, M. (2006). Complete predicted three-dimensional structure of the facilitator transmembrane protein and hepatitis C virus receptor CD81: conserved and variable structural domains in the tetraspanin superfamily. Biophys J 90, 212-227.
74. Seigneuret, M., Delaguillaumie, A., Lagaudrière-Gesbert, C. & Conjeaud, H. (2001). Structure of the tetraspanin main extracellular domain: a partially conserved fold with a structurally variable domain insertion. J Biol Chem 276, 40055-40064.
75. Shaw, M. L., McLauchlan, J., Mills, P. R., Patel, A. H. & McCruden, E. A. B. (2003). Characterisation of the differences between hepatitis C virus genotype 3 and 1 glycoproteins. J Med Virol 70, 361-372.
76. Silvie, O., Rubinstein, E., Franetich, J.-F. & 8 other authors (2003). Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity. Nat Med 9, 93-96.
77. Silvie, O., Franetich, J.-F., Renia, L. & Mazier, D. (2004). Malaria sporozoite: migrating for a living. Trends Mol Med 10, 97-100.
78. Stockert, R. J. (1995). The asialoglycoprotein receptor: relationships between structure, function, and expression. Physiol Rev 75, 591-609.
79. Tailor, C. S., Nouri, A. & Kabat, D. (2000). Cellular and species resistance to murine amphotropic, gibbon ape, and feline subgroup C leukemia viruses is strongly influenced by receptor expression levels and by receptor masking mechanisms. J Virol 74, 9797-9801.
80. Tailor, C. S., Lavillette, D., Marin, M. & Kabat, D. (2003). Cell surface receptors for gammaretroviruses. Curr Top Microbiol Immunol 281, 29-106.
81. Takeda, Y., Tachibana, I., Miyado, K. & 14 other authors (2003). Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes. J Cell Biol 161, 945-956.
82. Thomssen, R., Bonk, S., Propfe, C., Heermann, K. H., Kochel, H. G. & Uy, A. (1992). Association of hepatitis C virus in human sera with beta-lipoprotein. Med Microbiol Immunol (Berl) 181, 293-300.
83. Trigatti, B. L., Rigotti, A. & Braun, A. (2000). Cellular and physiological roles of SR-BI, a lipoprotein receptor which mediates selective lipid uptake. Biochim Biophys Acta 1529, 276-286.
84. van Kooyk, Y. & Geijtenbeek, T. B. H. (2003). DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol 3, 697-709.
85. Villanueva, R. A., Rouillé, Y. & Dubuisson, J. (2005). Interactions between virus proteins and host cell membranes during the viral life cycle. Int Rev Cytol 245, 171-244.
86. Viñals, M., Xu, S., Vasile, E. & Krieger, M. (2003). Identification of the N-linked glycosylation sites on the high density lipoprotein (HDL) receptor SR-BI and assessment of their effects on HDL binding and selective lipid uptake. J Biol Chem 278, 5325-5332.
87. Voisset, C., Callens, N., Blanchard, E., Op De Beeck, A., Dubuisson, J. & Vu-Dac, N. (2005). High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J Biol Chem 280, 7793-7799.
88. Wakita, T., Pietschmann, T., Kato, T. & 9 other authors (2005). Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11, 791-796.
89. Williams, D. L., Wong, J. S. & Hamilton, R. L. (2002). SR-BI is required for microvillar channel formation and the localization of HDL particles to the surface of adrenocortical cells in vivo. J Lipid Res 43, 544-549.
90. Wünschmann, S., Medh, J. D., Klinzmann, D., Schmidt, W. N. & Stapleton, J. T. (2000). Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J Virol 74, 10055-10062.
91. Yagnik, A. T., Lahm, A., Meola, A., Roccasecca, R. M., Ercole, B. B., Nicosia, A. & Tramontano, A. (2000). A model for the hepatitis C virus envelope glycoprotein E2. Proteins 40, 355-366.
92. Yamada, E., Montoya, M., Schuettler, C. G. & 7 other authors (2005). Analysis of the binding of hepatitis C virus genotype 1a and 1b E2 glycoproteins to peripheral blood mononuclear cell subsets. J Gen Virol 86, 2507-2512.
93. Zhang, J., Randall, G., Higginbottom, A., Monk, P., Rice, C. M. & McKeating, J. A. (2004). CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J Virol 78, 1448-1455.
94. Zhong, J., Gastaminza, P., Cheng, G. & 7 other authors (2005). Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 102, 9294-9299.
95. Zhu, G.-Z., Miller, B. J., Boucheix, C., Rubinstein, E., Liu, C. C., Hynes, R. O., Myles, D. G. & Primakoff, P. (2002). Residues SFQ (173-175) in the large extracellular loop of CD9 are required for gamete fusion. Development 129, 1995-2002.